FDA Orange Book · active-ingredient family
Epinephrine bitartrate
Epinephrine bitartrate is approved in 3 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE · NDA 218475
3
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · aerosol, metered, solution
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDERLD×2 | BAXTER HLTHCARE CORP | NDA 218475 | — | Mar 16, 2026 | |
| BRONITIN MIST | WYETH CONS | NDA 016126 | — | Approved Prior to Jan 1, 1982 | |
| MEDIHALER-EPI | 3M | NDA 010374 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Epinephrine bitartrate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

